Skip to main content Skip to navigation

News

  1. Glasses on a newspaper

    Plegridy (peginterferon beta-1a)

    21 May 2013

    Plegridy, a version of beta interferon that requires fewer injections, has been submitted for licensing in the USA based on the first year results of the two year ADVANCE trial. The trial is looking at one a fortnight and once a month doses. Initial results suggest reduction in relapses of about a third - similar to the existing beta interferon drugs.
    Read more…

  1. Small sample dishes

    Plegridy (peginterferon beta-1a)

    21 May 2013

    Plegridy, a version of beta interferon that requires fewer injections, has been submitted for licensing in the USA based on the first year results of the two year ADVANCE trial. The trial is looking at one a fortnight and once a month doses. Initial results suggest reduction in relapses of about a third - similar to the existing beta interferon drugs.
    Read more…

  1. Beaker and flask pouring blue liquid

    NHS physiotherapy provision is not meeting the needs of people with MS

    21 May 2013

    A recently published study carried out an in-depth analysis of the views of people with MS on physiotherapy services. The researchers evaluated comments made on physiotherapy provision from the 2008 MS Trust/Royal College of Physicians audit of MS services in England and Wales. Read more…

  1. MS Trust collection box

    Kayaker with MS completes Land's End to John O'Groats

    21 May 2013

    Glyn Brackenbury, who has MS, spent just over a month kayaking from Land's End to John O'Groats to raise funds for the MS Trust. He reached the end of his journey safely in John O'Groats yesterday (20 May). Read more…